Vivesto
0,288 SEK -0,52%1 investor følger denne virksomhed
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
VIVE
Daglig lav / høj pris
0,28 / 0,29
SEK
Markedsværdi
154,96 mio. SEK
Aktieomsætning
137,21 t SEK
Volumen
481 t
Seneste videoer
Finanskalender
Generalforsamling
23.05.2024
Delårsrapport
23.05.2024
Delårsrapport
22.08.2024
Delårsrapport
21.11.2024
Årsrapport
20.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Per Arwidsson med bolag | 24,8 % | 24,8 % |
Avanza Pension | 5,6 % | 5,6 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Vivesto to hold live-streamed Paccal Vet R&D Update on March 26
Vivesto doses first patient in its clinical Paccal Vet trial
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools